Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Borqs Technologies, Inc.BRQS · Entity 8297 | Director · Chair. of the Board, CEO & Pre | August 18, 2017 | August 22, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Borqs Technologies, Inc.
Report date August 18, 2017 · Filed August 22, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 687,361 |
Reported balance
After 2017-08-18 transaction · row 1
1 source rowRow 1 · 2017-08-18 · Grant · Acquired 687,361 · Balance 687,361 F1: Received in exchange for 8,793,914 ordinary shares of Borqs International Holding Corp. ("Borqs") in connection with the merger of Borqs into Pacific Special Acquisition Corp. (the "Merger"). |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.23 · Expires 2019-10-24 | Direct | 47,234 |
Reported balance
After 2017-08-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-08-18 · Grant · Acquired 47,234 · Balance 47,234 F2: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options are fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.92 · Expires 2021-07-23 | Direct | 30,060 |
Reported balance
After 2017-08-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-08-18 · Grant · Acquired 30,060 · Balance 30,060 F3: Received in the Merger in exchange for a stock option to acquire 318,200 ordinary shares of Borqs. The options are fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.92 · Expires 2022-05-26 | Direct | 1,719 |
Reported balance
After 2017-08-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-18 · Grant · Acquired 1,719 · Balance 1,719 F4: Received in the Merger in exchange for a stock option to acquire 18,200 ordinary shares of Borqs. The options are fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.86 · Expires 2023-04-26 | Direct | 3,211 |
Reported balance
After 2017-08-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-18 · Grant · Acquired 3,211 · Balance 3,211 F5: Received in the Merger in exchange for a stock option to acquire 34,000 ordinary shares of Borqs. The options are fully vested. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.86 · Expires 2025-05-29 | Direct | 1,983 |
Reported balance
After 2017-08-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-18 · Grant · Acquired 1,983 · Balance 1,983 F6: Received in the Merger in exchange for a stock option to acquire 21,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on May 30, 2016, and an additional 1/48 of the total grant vests each month thereafter. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.18 · Expires 2027-02-11 | Direct | 283,406 |
Reported balance
After 2017-08-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-18 · Grant · Acquired 283,406 · Balance 283,406 F7: Received in the Merger in exchange for a stock option to acquire 3,000,000 ordinary shares of Borqs. Two-thirds of options vested on February 12, 2017, and the remaining 1/3 of the options vests in equal increments monthly over 48 months beginning January 1, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Received in exchange for 8,793,914 ordinary shares of Borqs International Holding Corp. ("Borqs") in connection with the merger of Borqs into Pacific Special Acquisition Corp. (the "Merger").
F2: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options are fully vested.
F3: Received in the Merger in exchange for a stock option to acquire 318,200 ordinary shares of Borqs. The options are fully vested.
F4: Received in the Merger in exchange for a stock option to acquire 18,200 ordinary shares of Borqs. The options are fully vested.
F5: Received in the Merger in exchange for a stock option to acquire 34,000 ordinary shares of Borqs. The options are fully vested.
F6: Received in the Merger in exchange for a stock option to acquire 21,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on May 30, 2016, and an additional 1/48 of the total grant vests each month thereafter.
F7: Received in the Merger in exchange for a stock option to acquire 3,000,000 ordinary shares of Borqs. Two-thirds of options vested on February 12, 2017, and the remaining 1/3 of the options vests in equal increments monthly over 48 months beginning January 1, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 18, 2017 Filed Aug 22, 2017 16:55 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 283,406 | Not disclosed Strike: $7.18 | Not disclosed |
DisclosureSEC source: 0001213900-17-009092 · f4081817chanpat_borqstech.xml · derivative · entry 7 Chan Pat · CIK 0001389472 · Director · Chair. of the Board, CEO & Pre 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,406 Underlying: Ordinary Shares · 283,406 shares Expires 2027-02-11 F7 · price: Received in the Merger in exchange for a stock option to acquire 3,000,000 ordinary shares of Borqs. Two-thirds of options vested on February 12, 2017, and the remaining 1/3 of the options vests in equal increments monthly over 48 months beginning January 1, 2017. F7 · derivative.exercise_date: Received in the Merger in exchange for a stock option to acquire 3,000,000 ordinary shares of Borqs. Two-thirds of options vested on February 12, 2017, and the remaining 1/3 of the options vests in equal increments monthly over 48 months beginning January 1, 2017. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 16:55 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 1,983 | Not disclosed Strike: $4.86 | Not disclosed |
DisclosureSEC source: 0001213900-17-009092 · f4081817chanpat_borqstech.xml · derivative · entry 6 Chan Pat · CIK 0001389472 · Director · Chair. of the Board, CEO & Pre 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,983 Underlying: Ordinary Shares · 1,983 shares Expires 2025-05-29 F6 · price: Received in the Merger in exchange for a stock option to acquire 21,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on May 30, 2016, and an additional 1/48 of the total grant vests each month thereafter. F6 · derivative.exercise_date: Received in the Merger in exchange for a stock option to acquire 21,000 ordinary shares of Borqs. The options became vested as to 1/4 of the total grant on May 30, 2016, and an additional 1/48 of the total grant vests each month thereafter. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 16:55 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 3,211 | Not disclosed Strike: $4.86 | Not disclosed |
DisclosureSEC source: 0001213900-17-009092 · f4081817chanpat_borqstech.xml · derivative · entry 5 Chan Pat · CIK 0001389472 · Director · Chair. of the Board, CEO & Pre 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,211 Underlying: Ordinary Shares · 3,211 shares Expires 2023-04-26 F5 · price: Received in the Merger in exchange for a stock option to acquire 34,000 ordinary shares of Borqs. The options are fully vested. F5 · derivative.exercise_date: Received in the Merger in exchange for a stock option to acquire 34,000 ordinary shares of Borqs. The options are fully vested. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 16:55 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 1,719 | Not disclosed Strike: $2.92 | Not disclosed |
DisclosureSEC source: 0001213900-17-009092 · f4081817chanpat_borqstech.xml · derivative · entry 4 Chan Pat · CIK 0001389472 · Director · Chair. of the Board, CEO & Pre 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,719 Underlying: Ordinary Shares · 1,719 shares Expires 2022-05-26 F4 · price: Received in the Merger in exchange for a stock option to acquire 18,200 ordinary shares of Borqs. The options are fully vested. F4 · derivative.exercise_date: Received in the Merger in exchange for a stock option to acquire 18,200 ordinary shares of Borqs. The options are fully vested. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 16:55 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 30,060 | Not disclosed Strike: $2.92 | Not disclosed |
DisclosureSEC source: 0001213900-17-009092 · f4081817chanpat_borqstech.xml · derivative · entry 3 Chan Pat · CIK 0001389472 · Director · Chair. of the Board, CEO & Pre 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,060 Underlying: Ordinary Shares · 30,060 shares Expires 2021-07-23 F3 · price: Received in the Merger in exchange for a stock option to acquire 318,200 ordinary shares of Borqs. The options are fully vested. F3 · derivative.exercise_date: Received in the Merger in exchange for a stock option to acquire 318,200 ordinary shares of Borqs. The options are fully vested. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 16:55 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantStock Option (Right to Buy) · Derivative | 47,234 | Not disclosed Strike: $2.23 | Not disclosed |
DisclosureSEC source: 0001213900-17-009092 · f4081817chanpat_borqstech.xml · derivative · entry 2 Chan Pat · CIK 0001389472 · Director · Chair. of the Board, CEO & Pre 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,234 Underlying: Ordinary Shares · 47,234 shares Expires 2019-10-24 F2 · price: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options are fully vested. F2 · derivative.exercise_date: Received in the Merger in exchange for a stock option to acquire 500,000 ordinary shares of Borqs. The options are fully vested. Read SEC document |
| August 18, 2017 Filed Aug 22, 2017 16:55 UTC | Borqs Technologies, Inc. BRQS · Entity 8297 | GrantOrdinary Shares | 687,361 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-17-009092 · f4081817chanpat_borqstech.xml · nonDerivative · entry 1 Chan Pat · CIK 0001389472 · Director · Chair. of the Board, CEO & Pre 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 687,361 F1 · price: Received in exchange for 8,793,914 ordinary shares of Borqs International Holding Corp. ("Borqs") in connection with the merger of Borqs into Pacific Special Acquisition Corp. (the "Merger"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.